Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection.
Ontology highlight
ABSTRACT: Tuberculosis relapse following drug treatment of active disease is an important global public health problem due to the poorer clinical outcomes and increased risk of drug resistance development. Concurrent infection with HIV, including in those receiving anti-retroviral therapy (ART), is an important risk factor for relapse and expansion of drug resistant Mycobacterium tuberculosis (Mtb) isolates. A greater understanding of the HIV-associated factors driving TB relapse is important for development of interventions that support immune containment and complement drug therapy. We employed the humanized mouse to develop a new model of post-chemotherapy TB relapse in the setting of HIV infection. Paucibacillary TB infection was observed following treatment with Rifampin and Isoni
SUBMITTER: Huante MB
PROVIDER: S-EPMC7176873 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA